DKK1 and lung cancer: DKK1 is a WNT pathway inhibitor that has been shown to be of prognostic significance in diverse tumor entities such as breast cancer, lung cancer, myeloma but also in esophageal carcinoma.[30]–[38] In addition DKK1 was reported to be elevated in the serum of ESC patients[37].